메뉴 건너뛰기




Volumn 1, Issue 5, 2007, Pages 497-501

Evaluating Therapeutic Efficacy against Cancer Stem Cells: New Challenges Posed by a New Paradigm

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; BONE MORPHOGENETIC PROTEIN; CD123 ANTIGEN; CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H90; PARTHENOLIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAPAMYCIN; UNCLASSIFIED DRUG;

EID: 35848968478     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.10.005     Document Type: Note
Times cited : (53)

References (27)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.